VF

VIVES Funds

Europe, Brabant Wallon, Belgium, Wavre

Description

VIVES Funds is a seed capital fund.

Investor Profile

VIVES Funds has backed more than 5 startups, with 4 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A rounds (top funding stages).
  • Majority of deals are located in Belgium, France.
  • Strong thematic focus on Biotechnology, Therapeutics, Life Science.
  • Led 2 rounds in the past year.

Stage Focus

  • Seed (60%)
  • Series A (40%)

Country Focus

  • Belgium (60%)
  • France (40%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Life Science
  • Medical
  • Medical Device
  • Health Care
  • Agriculture
  • Farming
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does VIVES Funds frequently co-invest with?

GO CAPITAL
Europe, Bretagne, France, Rennes
Co-Investments: 1
Innovation Fund
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
UI Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
I
Europe, Liege, Belgium, Seraing
Co-Investments: 1
I
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 2
ME
Europe, Ile-de-France, France, Paris
Co-Investments: 1
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 1
WING by Digital Wallonia
Europe, Liege, Belgium, Liège
Co-Investments: 1
Better Angle
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by VIVES Funds?

Nuclidium

Basel, Basel-Stadt, Switzerland

Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.

Health CareHealth DiagnosticsMedicalTherapeutics
Series BJul 10, 2025
Amount Raised: $99,518,156
BiocSol

Louvain-la-neuve, Vlaams-Brabant, Belgium

BiocSol focus on sustainable microbial-based crop protection.

AgricultureBiotechnologyFarming
SeedNov 20, 2024
Amount Raised: $5,483,815
ATB Therapeutics

Aye, Luxembourg, Belgium

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

BiotechnologyHealth CareTherapeutics
Series ANov 18, 2024
Amount Raised: $57,210,541
Generare

Paris, Ile-de-France, France

Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.

Biotechnology
SeedOct 7, 2024
Amount Raised: $5,487,149
Brightflow

Paris, Ile-de-France, France

Brightflow operates as a medical device startup.

MedicalMedical Device
Series ASep 10, 2024
Amount Raised: $18,183,541
VOCSense

Mont-saint-guibert, Brabant Wallon, Belgium

VOCSens spin-off is developing a new concept of an environmental camera.

BiotechnologyLife ScienceTherapeutics
SeedSep 24, 2021
Amount Raised: $2,930,138